Literature DB >> 9746224

In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess.

J Campión1, V Lahera, V Cachofeiro, B Maestro, N Dávila, M C Carranza, C Calle.   

Abstract

Insulin receptor (IR) gene expression at the mRNA level was investigated in hindlimb skeletal muscle, epididymal adipose tissue and in the liver of rats exposed to prolonged in vivo administration of deoxycorticosterone acetate (DOCA). Following treatment, plasma insulin levels were reduced while glucose levels increased compared to values in control rats. DOCA-treated animals showed an increase in blood pressure and a reduction in body weight. This treatment also induced hypokalemia and decreased plasma protein levels. Sodium levels were unaffected. Moreover, no differences in DNA and protein content or in the indicator of cell size (protein/DNA) were observed in the skeletal muscle or adipose tissue of animals. In contrast, there was a clear increase in the protein and DNA contents of the liver with no change in the indicator of cell size. Northern blot assays revealed 2 major IR mRNA species of approximately 9.5 and 7.5 Kb in the 3 tissues from control animals. DOCA treatment induced no change in the levels of either RNA species in skeletal muscle. However, a decrease of approximately 22% was detected in the levels of both species in adipose tissue whereas the liver showed an increase of 64%. These results provide the first evidence for an in vivo tissue-specific modulation of IR mRNA levels under experimental conditions of mineralocorticoid excess.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746224     DOI: 10.1023/a:1006871309864

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

Review 1.  CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

Authors:  J W CONN; R F KNOPF; R M NESBIT
Journal:  Am J Surg       Date:  1964-01       Impact factor: 2.565

2.  Insulin receptor gene expression in skeletal muscle and brown adipose tissue.

Authors:  R M Knott; J E Hesketh; P Trayhurn
Journal:  Biochem Soc Trans       Date:  1990-12       Impact factor: 5.407

Review 3.  Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance.

Authors:  J W Funder
Journal:  Annu Rev Med       Date:  1997       Impact factor: 13.739

Review 4.  Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action.

Authors:  T Trapp; F Holsboer
Journal:  Trends Pharmacol Sci       Date:  1996-04       Impact factor: 14.819

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

Review 6.  Aldosterone action.

Authors:  J W Funder
Journal:  Annu Rev Physiol       Date:  1993       Impact factor: 19.318

7.  Insulin receptor mRNA levels are modulated in a tissue-specific manner in Cushing's syndrome patients.

Authors:  M A Leal; P Aller; A Torres; A Picardo; N Dávila; C Calle
Journal:  Horm Metab Res       Date:  1994-07       Impact factor: 2.936

8.  Glucocorticoid receptors in adipose tissue.

Authors:  D Feldman; D Loose
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

9.  Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor.

Authors:  J Sauer; M Castren; U Hopfner; F Holsboer; G K Stalla; E Arzt
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

10.  Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats.

Authors:  J Navarro; A Sanchez; J Sáiz; L M Ruilope; J García-Estań; J C Romero; S Moncada; V Lahera
Journal:  Am J Physiol       Date:  1994-12
View more
  6 in total

1.  Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice.

Authors:  Justin L Grobe; Beth A Buehrer; Aline M Hilzendeger; Xuebo Liu; Deborah R Davis; Di Xu; Curt D Sigmund
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

Review 2.  Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.

Authors:  Adam Whaley-Connell; Megan S Johnson; James R Sowers
Journal:  Prog Cardiovasc Dis       Date:  2010 Mar-Apr       Impact factor: 8.194

Review 3.  The effect of aldosterone on glucose metabolism.

Authors:  Dalila B Corry; Michael L Tuck
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 4.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

Review 5.  Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far?

Authors:  Huai Heng Loh; Norlela Sukor
Journal:  J Hum Hypertens       Date:  2019-12-10       Impact factor: 3.012

Review 6.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.